Skip to content

4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one

C18H19F2N5O2 — CID 123463097

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one
SMILESCC(Oc1cc(-c2cnn(CC(F)F)c2)cn2nccc12)C1CNC(=O)C1
InChIInChI=1S/C18H19F2N5O2/c1-11(12-5-18(26)21-6-12)27-16-4-13(9-25-15(16)2-3-22-25)14-7-23-24(8-14)10-17(19)20/h2-4,7-9,11-12,17H,5-6,10H2,1H3,(H,21,26)
InChIKeyPKPAIIYIFLCTNQ-UHFFFAOYSA-N
MW375.38 g/mol
LogP2.37
Rot. Bonds6

About 4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one

4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one (PubChem CID 123463097) has the molecular formula C18H19F2N5O2 and a molecular weight of 375.38 g/mol. Its IUPAC name is 4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one.

Molecular Properties

Compound Name4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one
PubChem CID123463097
Molecular FormulaC18H19F2N5O2
Molecular Weight375.38 g/mol
Exact Mass375.15
IUPAC Name4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one
SMILESCC(Oc1cc(-c2cnn(CC(F)F)c2)cn2nccc12)C1CNC(=O)C1
InChIInChI=1S/C18H19F2N5O2/c1-11(12-5-18(26)21-6-12)27-16-4-13(9-25-15(16)2-3-22-25)14-7-23-24(8-14)10-17(19)20/h2-4,7-9,11-12,17H,5-6,10H2,1H3,(H,21,26)
InChIKeyPKPAIIYIFLCTNQ-UHFFFAOYSA-N
XLogP2.37
TPSA73.45 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms27
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500375.38
LogP ≤ 52.37
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze 4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one?
The IUPAC name of 4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one (CID 123463097) is 4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one.
What is the SMILES notation for 4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one?
The canonical SMILES for 4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one is CC(Oc1cc(-c2cnn(CC(F)F)c2)cn2nccc12)C1CNC(=O)C1.
What is the InChIKey of 4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one?
The InChIKey is PKPAIIYIFLCTNQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H19F2N5O2/c1-11(12-5-18(26)21-6-12)27-16-4-13(9-25-15(16)2-3-22-25)14-7-23-24(8-14)10-17(19)20/h2-4,7-9,11-12,17H,5-6,10H2,1H3,(H,21,26).
What are the key properties of 4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one?
4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one has a molecular weight of 375.38 g/mol, XLogP of 2.37, 6 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[1-[6-[1-(2,2-difluoroethyl)pyrazol-4-yl]pyrazolo[1,5-a]pyridin-4-yl]oxyethyl]pyrrolidin-2-one is sourced from PubChem (CID 123463097), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.